[Regression of a pituitary tumor, associated with primary hyperthyroidism, under the effect of 1-thyroxine].
The authors report on a successful medical treatment of a 36-year-old woman who had hypothyroidism and pituitary adenoma. Primary hypothyroidism was evidenced by decreased serum thyroxine (23 nmol/l; 1,77 micrograms/dl) and increased plasma thyroid-stimulating hormone (TSH) levels (108 mU/l). Pituitary mass with suprasellar expansion (1 cm in diameter) was proven by computed tomography (CT). The patient had been treated conventionally with 1-thyroxine and this medication was continued during a 1-year follow-up. Not only did she become symptom-free but control CT scanning revealed a large reduction of tumor size and the disappearance of suprasellar expansion.
Tóth
M
M
Rácz
K
K
Novák
K
K
Kiss
R
R
Mohari
K
K
Fehér
J
J
Gláz
E
E
D000328:Adult; D005687:Galactorrhea / Q000209:etiology; D006801:Humans; D007037:Hypothyroidism / Q000150:complications* / Q000188:drug therapy; D008297:Male; D010911:Pituitary Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D015175:Prolactinoma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012074:Remission Induction; D013974:Thyroxine / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
D013974:Thyroxine
Primer hypothyreosishoz társuló hypophysis-tumor regressiója l-thyroxin hatására.